Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1986 2
1987 2
1988 3
1990 3
1991 1
1995 1
1997 1
1998 2
1999 1
2000 3
2002 2
2003 1
2004 1
2006 1
2007 3
2009 2
2010 1
2012 1
2013 2
2014 1
2015 1
2017 4
2018 1
2019 1
2020 2
2021 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Adult T-Cell Leukemia/Lymphoma.
Mehta-Shah N, Ratner L, Horwitz SM. Mehta-Shah N, et al. J Oncol Pract. 2017 Aug;13(8):487-492. doi: 10.1200/JOP.2017.021907. J Oncol Pract. 2017. PMID: 28796966 Free PMC article. Review.
In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, and smoldering forms) defined by the presenting features, and therefore, the clinical course …
In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical …
Caribbean T-cell lymphoma/leukemia.
Swerdlow SH, Habeshaw JA, Rohatiner AZ, Lister TA, Stansfeld AG. Swerdlow SH, et al. Cancer. 1984 Aug 15;54(4):687-96. doi: 10.1002/1097-0142(1984)54:4<687::aid-cncr2820540416>3.0.co;2-g. Cancer. 1984. PMID: 6234983
The disease was usually characterized by adenopathy (with or without hepatosplenomegaly), peripheral blood involvement, hypercalcemia often in the absence of gross bony lesions, and a poor prognosis. The neoplastic cells were pleomorphic with marked nuclear irregularity of …
The disease was usually characterized by adenopathy (with or without hepatosplenomegaly), peripheral blood involvement, hypercalcemia often …
Cutaneous T-cell lymphoma/leukemia.
Siegel RS, Kuzel TM. Siegel RS, et al. Curr Treat Options Oncol. 2000 Apr;1(1):43-50. doi: 10.1007/s11864-000-0014-0. Curr Treat Options Oncol. 2000. PMID: 12057060 Review.
Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach.
Forghani-Ramandi MM, Mostafavi B, Bahavar A, Dehghankar M, Siami Z, Mozhgani SH. Forghani-Ramandi MM, et al. Virus Res. 2023 Dec;338:199237. doi: 10.1016/j.virusres.2023.199237. Epub 2023 Oct 23. Virus Res. 2023. PMID: 37832654 Free PMC article.
BACKGROUND: Adult T-cell leukemia/lymphoma (ATLL) is a poor prognosis malignancy of peripheral T-cells caused by human T-cell leukemia virus type 1 (HTLV-1). ...
BACKGROUND: Adult T-cell leukemia/lymphoma (ATLL) is a poor prognosis malignancy of peripheral T-cells caused by human T-cell leukemi …
Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute.
Ruiz R, Morante Z, Mantilla R, Mas L, Casanova L, Gomez HL. Ruiz R, et al. An Bras Dermatol. 2017 Sep-Oct;92(5):649-654. doi: 10.1590/abd1806-4841.20176825. An Bras Dermatol. 2017. PMID: 29166501 Free PMC article.
High risk group (HR: 4.6 [2.08-10.18]) and increased DHL level (HR: 3.2 [1.57-6.46]) emerged as prognostic factors for survival. STUDY LIMITATIONS: Small series. CONCLUSION: Primary cutaneous T-cell lymphomas other than mycosis fungoides or CD30+ lymphoproliferative disord …
High risk group (HR: 4.6 [2.08-10.18]) and increased DHL level (HR: 3.2 [1.57-6.46]) emerged as prognostic factors for survival. STUD …
T-cell lymphoma in HIV-infected patients.
Arzoo KK, Bu X, Espina BM, Seneviratne L, Nathwani B, Levine AM. Arzoo KK, et al. J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1020-7. doi: 10.1097/00126334-200408150-00004. J Acquir Immune Defic Syndr. 2004. PMID: 15247554
Models for mature T-cell lymphomas--a critical appraisal of experimental systems and their contribution to current T-cell tumorigenic concepts.
Warner K, Crispatzu G, Al-Ghaili N, Weit N, Florou V, You MJ, Newrzela S, Herling M. Warner K, et al. Crit Rev Oncol Hematol. 2013 Dec;88(3):680-95. doi: 10.1016/j.critrevonc.2013.07.014. Epub 2013 Aug 21. Crit Rev Oncol Hematol. 2013. PMID: 23972664 Review.
Our historically rudimentary molecular understanding and dissatisfactory interventional success in this complex and for the most part poor-prognostic group of tumors is only slightly improving. A major limiting aspect in further progress in these rare neoplasms is the lack …
Our historically rudimentary molecular understanding and dissatisfactory interventional success in this complex and for the most part poor- …
18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma.
Casulo C, Schöder H, Feeney J, Lim R, Maragulia J, Zelenetz AD, Horwitz S. Casulo C, et al. Leuk Lymphoma. 2013 Oct;54(10):2163-7. doi: 10.3109/10428194.2013.767901. Epub 2013 Mar 4. Leuk Lymphoma. 2013. PMID: 23369041 Free PMC article.
In the present analysis we examined the impact of FDG-PET on the initial staging of peripheral T cell lymphomas (PTCLs), and the prognostic value of interim FDG-PET. This retrospective analysis identified patients with mature T or natural killer (NK) lymphomas who had PET …
In the present analysis we examined the impact of FDG-PET on the initial staging of peripheral T cell lymphomas (PTCLs), and the prognost …
48 results